GLUE vs PDD · rev $13.2M vs P/E 8.4, rev $61.75B
Monte Rosa Therapeutics Inc (GLUE) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
GLUE currently screens at market cap $1.56B. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the GLUE and PDD stock pages for the full models.
Not investment advice.